Price
Target price
€26.40
€26.40
3.940%
1.0
3.940%
€34.68
23.05.24 / Stuttgart Stock Exchange
WKN: 897013 / Symbol: IART / Name: Integra / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Integra LifeSciences Holdings Corp Stock
Integra LifeSciences Holdings Corp dominated the market today, gaining €1.00 (3.940%).
With 3 Buy predictions and 3 Sell predictions the community is currently undecided on Integra LifeSciences Holdings Corp.
With a target price of 34 € there is a positive potential of 28.79% for Integra LifeSciences Holdings Corp compared to the current price of 26.4 €.
Pros and Cons of Integra LifeSciences Holdings Corp in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
S********** s********
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Integra LifeSciences Holdings Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Integra LifeSciences Holdings Corp | 3.940% | 4.762% | -1.493% | -28.261% | -32.995% | -54.872% | -38.690% |
| Neogen Corp. | 1.650% | 1.653% | 8.850% | -18.000% | -32.787% | -67.632% | -51.335% |
| Bio-Rad Labs Inc. A | 0.260% | -2.647% | 1.846% | -25.450% | -9.809% | -45.738% | - |
| Merit Medical Systems | -1.320% | 0.000% | 7.971% | -0.667% | 9.559% | 51.423% | 61.325% |
Comments
Integra LifeSciences Holdings Co. (NASDAQ: IART) had its price target lowered by analysts at Morgan Stanley from $37.00 to $24.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ: IART) had its price target lowered by analysts at Bank of America Co. from $42.00 to $26.00. They now have an "underperform" rating on the stock.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ: IART) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for IART provided by MarketBeat